Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,141.21
(
0.05%
)
US TECH 100
26,241.20
(
0.14%
)
Dow Jones
49,425.43
(
-0.13%
)
Brent Oil
98.75
(
2.09%
)
Bitcoin
78,403.50
(
0.21%
)
News Focus
News Focus
Post# of 257438
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

masterlongevity

Send PM Follow Ignore
Followers 24
Posts 2597
Boards Moderated 0
Alias Born 01/07/2004

masterlongevity

Re: DewDiligence post# 72211

Monday, 01/26/2009 11:52:13 PM

Monday, January 26, 2009 11:52:13 PM

Post# of 257438
Bapineuzimab..

i agree. Would not be surprised if they booted it back to Elan...
i think elan is in real trouble. tysabri is going to have some new stiff competition in 1 yr and bapineuzimab is still 3+ yrs from market, assuming it works.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today